$ARVN
Arvinas, Inc
XNAS•Health Care•Pharmaceutical Preparations
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateWhy is ARVN up today? It is at $7.51 (+0.00%), and our scanner flagged it 39 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ARVN spikes, and full due diligence on ARVN — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ARVN 39 times in the last 30 days. Create a free account to track $ARVN, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ARVN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ARVN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Latest filingS-8Employee share plan registration (S-8)Sep 28, 2026 · 10 days ago| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Saik Andrew Officer | Sold (automatic/other) | -6K | sold 2.9% | 187K | $46K at $8.16 | Jun 24, 26 |
Bain Linda Director | Acquired (grant/award) | +16K 0.02% of company | added 60% | 42K | n/a | Jun 24, 26 |
Cunningham Everett Director | Acquired (grant/award) | +16K 0.02% of company | added 60% | 42K | n/a | Jun 24, 26 |
Kennedy Edward Moore Jr. Director | Acquired (grant/award) | +16K 0.02% of company | added 39% | 55K | n/a | Jun 24, 26 |
Morrison Briggs Director | Acquired (grant/award) | +16K 0.02% of company | added 16% | 112K | n/a | Jun 24, 26 |
Norwalk Leslie V Director | Acquired (grant/award) | +16K 0.02% of company | added 60% | 42K | n/a | Jun 24, 26 |
Smaldone Alsup Laurie Director | Acquired (grant/award) | +16K 0.02% of company | added 60% | 42K | n/a | Jun 24, 26 |
Cacace Angela M Officer | Sold (automatic/other) | -3K | sold 1.4% | 180K | $20K at $7.59 | Jun 17, 26 |
Teel Randy Officer | Sold (automatic/other) | -2K | sold 0.8% | 285K | $20K at $9.04 | May 21, 26 |
Teel Randy Officer | Sold (automatic/other) | -10K 0.01% of company | sold 3.3% | 287K | $96K at $9.94 | May 11, 26 |
Berkowitz Noah Officer | Sold (automatic/other) | -11K 0.02% of company | sold 5.5% | 191K | $110K at $9.94 | May 11, 26 |
Cacace Angela M Officer | Sold (automatic/other) | -10K 0.01% of company | sold 5.0% | 183K | $96K at $9.94 | May 11, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on ARVN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ARVN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
ARVN last traded at $7.51, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Arvinas, Inc (ARVN) is next expected to report earnings on Wednesday, November 4, 2026, about 27 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The ARVN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ARVN 39 times in the last 30 days.
ARVN (Arvinas, Inc) trades on XNAS, with a market cap of about $491M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ARVN for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ARVN discussion
Sign in to ask a question or join the discussion.